SYNERGISTIC TARGETING OF PI3K/AKT-PATHWAY AND ANDROGEN-RECEPTOR AXIS SIGNIFICANTLY DELAYS CASTRATION-RESISTANT PROSTATE CANCER PROGRESSION IN VIVO

被引：0
|
作者：
Thomas, Christian
Lamoureux, Francois
Crafter, Claire
Davies, Barry
Beraldi, Eliana
Fazli, Ladan
Kim, Soojin
Thaper, Daksh
Gleave, Martin
Zoubeidi, Amina
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.1703
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
318
引用
收藏
页码：E129 / E129
页数：1
相关论文
共 50 条
  • [41] Targeting the FGFR pathway in androgen receptor negative castration resistant prostate cancer
    Morrissey, Colm
    Corey, Eva
    Brown, Lisha
    Coleman, Ilsa
    Nguyen, Holly
    Schweizer, Michael
    Nelson, Peter
    CANCER RESEARCH, 2017, 77
  • [42] Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review)
    Toren, Paul
    Zoubeidi, Amina
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (05) : 1793 - 1801
  • [43] Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer
    Pak, Sahyun
    Suh, Jungyo
    Park, Seo Young
    Kim, Yunlim
    Cho, Yong Mee
    Ahn, Hanjong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer
    Shiota, Masaki
    Yokomizo, Akira
    Naito, Seiji
    FREE RADICAL BIOLOGY AND MEDICINE, 2011, 51 (07) : 1320 - 1328
  • [45] siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway
    Yu, Yanling
    Papukashvili, Dimitri
    Ren, Ruimin
    Rcheulishvili, Nino
    Feng, Shunping
    Bai, Wenqi
    Zhang, Huanhu
    Xi, Yanfeng
    Lu, Xiaoqing
    Xing, Nianzeng
    FUTURE ONCOLOGY, 2023, 19 (30) : 2055 - 2073
  • [46] Targeting the DNA-binding domain of the androgen receptor in castration-resistant prostate cancer
    Steele, Thomas M.
    Messner, Elisabeth A.
    Tsamouri, Maria Malvina
    Siddiqui, Salma
    Bennion, Brian
    Liu, Ruiwu
    Ghosh, Paramita
    CANCER RESEARCH, 2022, 82 (12)
  • [47] Androgen receptor degraders and transactivation domain inhibitors targeting castration-resistant prostate cancer
    Elshan, N. G. Ralalage Dayan
    An, Jiabin
    Jung, Michael
    Rettig, Matthew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [48] Synthesis of curcumin derivatives targeting androgen receptor for castration-resistant prostate cancer therapy
    Liu, Jiangfei
    Ni, Yaohui
    Zhou, Keyun
    Wu, Guanzhao
    Hu, Liangyong
    Zhu, Tianyu
    Xu, Defeng
    Hu, Hang
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 104 (01)
  • [49] Mechanisms of acquired resistance to androgen receptor targeting drugs in castration-resistant prostate cancer
    Chism, David D.
    De Silva, Dinuka
    Whang, Young E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (11) : 1369 - 1378
  • [50] Dual Targeting of Androgen Receptor and PI3K/AKT/mTOR Pathways in Prostate Cancer By Salinomycin: A Contrast to Rapamycin
    Mirkheshti, Nooshin
    Chatterjee, Bandana
    Song, Chung Seog
    ENDOCRINE REVIEWS, 2014, 35 (03)
12345